James Love

James Love is an accomplished professional in the field of structural biology and digital science innovation, currently serving as Vice President of Cross Modalities Workflows and Vice President of Automation and Process Optimization at Novo Nordisk since April 2019. Love also holds the position of Director at the Protein Expression and Purification journal with Elsevier since February 2017, and previously served as Executive Editor at Protein Innovation Labs, Inc. and President of the Institute for Protein Innovation. Prior experience includes various leadership roles at DNA2.0 (now ATUM) as Chief Operating Officer and Director of Expression Technologies, as well as Director of Technology Development at Albert Einstein College of Medicine. Love's academic credentials include a postdoctoral research position at Columbia University, a PhD from the University of Cambridge, and a Master’s degree from the University of Oxford.